United States Dry Powder Inhaler Device Market Report 2018

Publisher Name :
Date: 07-Jun-2018
No. of pages: 109
Inquire Before Buying

In this report, the United States Dry Powder Inhaler Device market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Dry Powder Inhaler Device in these regions, from 2013 to 2025 (forecast).

United States Dry Powder Inhaler Device market competition by top manufacturers/players, with Dry Powder Inhaler Device sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- GlaxoSmithKline

- AstraZeneca

- Boehringer Ingelheim

- Chiesi

- Cipla

- 3M

- Hovione

- Mannkind

- Meda

- Novartis

- Schering/Merck

- Teva

- Vectura

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Single Dose

- Multi-dose

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Asthma

- COPD

- Other

United States Dry Powder Inhaler Device Market Report 2018

Table of Contents
United States Dry Powder Inhaler Device Market Report 2018
1 Dry Powder Inhaler Device Overview
1.1 Product Overview and Scope of Dry Powder Inhaler Device
1.2 Classification of Dry Powder Inhaler Device by Product Category
1.2.1 United States Dry Powder Inhaler Device Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Dry Powder Inhaler Device Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Single Dose
1.2.4 Multi-dose
1.3 United States Dry Powder Inhaler Device Market by Application/End Users
1.3.1 United States Dry Powder Inhaler Device Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Other
1.4 United States Dry Powder Inhaler Device Market by Region
1.4.1 United States Dry Powder Inhaler Device Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Dry Powder Inhaler Device Status and Prospect (2013-2025)
1.4.3 Southwest Dry Powder Inhaler Device Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Dry Powder Inhaler Device Status and Prospect (2013-2025)
1.4.5 New England Dry Powder Inhaler Device Status and Prospect (2013-2025)
1.4.6 The South Dry Powder Inhaler Device Status and Prospect (2013-2025)
1.4.7 The Midwest Dry Powder Inhaler Device Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Dry Powder Inhaler Device (2013-2025)
1.5.1 United States Dry Powder Inhaler Device Sales and Growth Rate (2013-2025)
1.5.2 United States Dry Powder Inhaler Device Revenue and Growth Rate (2013-2025)
2 United States Dry Powder Inhaler Device Market Competition by Players/Suppliers
2.1 United States Dry Powder Inhaler Device Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Dry Powder Inhaler Device Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Dry Powder Inhaler Device Average Price by Players/Suppliers (2013-2018)
2.4 United States Dry Powder Inhaler Device Market Competitive Situation and Trends
2.4.1 United States Dry Powder Inhaler Device Market Concentration Rate
2.4.2 United States Dry Powder Inhaler Device Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Dry Powder Inhaler Device Manufacturing Base Distribution, Sales Area, Product Type
3 United States Dry Powder Inhaler Device Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Dry Powder Inhaler Device Sales and Market Share by Region (2013-2018)
3.2 United States Dry Powder Inhaler Device Revenue and Market Share by Region (2013-2018)
3.3 United States Dry Powder Inhaler Device Price by Region (2013-2018)
4 United States Dry Powder Inhaler Device Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Dry Powder Inhaler Device Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Dry Powder Inhaler Device Revenue and Market Share by Type (2013-2018)
4.3 United States Dry Powder Inhaler Device Price by Type (2013-2018)
4.4 United States Dry Powder Inhaler Device Sales Growth Rate by Type (2013-2018)
5 United States Dry Powder Inhaler Device Sales (Volume) by Application (2013-2018)
5.1 United States Dry Powder Inhaler Device Sales and Market Share by Application (2013-2018)
5.2 United States Dry Powder Inhaler Device Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Dry Powder Inhaler Device Players/Suppliers Profiles and Sales Data
6.1 GlaxoSmithKline
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Dry Powder Inhaler Device Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 AstraZeneca
6.2.2 Dry Powder Inhaler Device Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim
6.3.2 Dry Powder Inhaler Device Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Chiesi
6.4.2 Dry Powder Inhaler Device Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Cipla
6.5.2 Dry Powder Inhaler Device Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 3M
6.6.2 Dry Powder Inhaler Device Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 3M Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Hovione
6.7.2 Dry Powder Inhaler Device Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Mannkind
6.8.2 Dry Powder Inhaler Device Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Meda
6.9.2 Dry Powder Inhaler Device Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Meda Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Novartis
6.10.2 Dry Powder Inhaler Device Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Schering/Merck
6.12 Teva
6.13 Vectura
7 Dry Powder Inhaler Device Manufacturing Cost Analysis
7.1 Dry Powder Inhaler Device Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dry Powder Inhaler Device
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Dry Powder Inhaler Device Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dry Powder Inhaler Device Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Dry Powder Inhaler Device Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Dry Powder Inhaler Device Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Dry Powder Inhaler Device Sales Volume Forecast by Type (2018-2025)
11.3 United States Dry Powder Inhaler Device Sales Volume Forecast by Application (2018-2025)
11.4 United States Dry Powder Inhaler Device Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Dry Powder Inhaler Device
Figure United States Dry Powder Inhaler Device Market Size (K Units) by Type (2013-2025)
Figure United States Dry Powder Inhaler Device Sales Volume Market Share by Type (Product Category) in 2017
Figure Single Dose Product Picture
Figure Multi-dose Product Picture
Figure United States Dry Powder Inhaler Device Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Dry Powder Inhaler Device by Application in 2017
Figure Asthma Examples
Table Key Downstream Customer in Asthma
Figure COPD Examples
Table Key Downstream Customer in COPD
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Dry Powder Inhaler Device Market Size (Million USD) by Region (2013-2025)
Figure The West Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2025)
Figure United States Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Dry Powder Inhaler Device Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Dry Powder Inhaler Device Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Dry Powder Inhaler Device Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Dry Powder Inhaler Device Sales Share by Players/Suppliers
Figure 2017 United States Dry Powder Inhaler Device Sales Share by Players/Suppliers
Figure United States Dry Powder Inhaler Device Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Dry Powder Inhaler Device Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Dry Powder Inhaler Device Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Dry Powder Inhaler Device Revenue Share by Players/Suppliers
Figure 2017 United States Dry Powder Inhaler Device Revenue Share by Players/Suppliers
Table United States Market Dry Powder Inhaler Device Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Dry Powder Inhaler Device Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Dry Powder Inhaler Device Market Share of Top 3 Players/Suppliers
Figure United States Dry Powder Inhaler Device Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Dry Powder Inhaler Device Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Dry Powder Inhaler Device Product Category
Table United States Dry Powder Inhaler Device Sales (K Units) by Region (2013-2018)
Table United States Dry Powder Inhaler Device Sales Share by Region (2013-2018)
Figure United States Dry Powder Inhaler Device Sales Share by Region (2013-2018)
Figure United States Dry Powder Inhaler Device Sales Market Share by Region in 2017
Table United States Dry Powder Inhaler Device Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Dry Powder Inhaler Device Revenue Share by Region (2013-2018)
Figure United States Dry Powder Inhaler Device Revenue Market Share by Region (2013-2018)
Figure United States Dry Powder Inhaler Device Revenue Market Share by Region in 2017
Table United States Dry Powder Inhaler Device Price (USD/Unit) by Region (2013-2018)
Table United States Dry Powder Inhaler Device Sales (K Units) by Type (2013-2018)
Table United States Dry Powder Inhaler Device Sales Share by Type (2013-2018)
Figure United States Dry Powder Inhaler Device Sales Share by Type (2013-2018)
Figure United States Dry Powder Inhaler Device Sales Market Share by Type in 2017
Table United States Dry Powder Inhaler Device Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Dry Powder Inhaler Device Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Dry Powder Inhaler Device by Type (2013-2018)
Figure Revenue Market Share of Dry Powder Inhaler Device by Type in 2017
Table United States Dry Powder Inhaler Device Price (USD/Unit) by Types (2013-2018)
Figure United States Dry Powder Inhaler Device Sales Growth Rate by Type (2013-2018)
Table United States Dry Powder Inhaler Device Sales (K Units) by Application (2013-2018)
Table United States Dry Powder Inhaler Device Sales Market Share by Application (2013-2018)
Figure United States Dry Powder Inhaler Device Sales Market Share by Application (2013-2018)
Figure United States Dry Powder Inhaler Device Sales Market Share by Application in 2017
Table United States Dry Powder Inhaler Device Sales Growth Rate by Application (2013-2018)
Figure United States Dry Powder Inhaler Device Sales Growth Rate by Application (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Dry Powder Inhaler Device Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Dry Powder Inhaler Device Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Dry Powder Inhaler Device Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Dry Powder Inhaler Device Sales Growth Rate (2013-2018)
Figure AstraZeneca Dry Powder Inhaler Device Sales Market Share in United States (2013-2018)
Figure AstraZeneca Dry Powder Inhaler Device Revenue Market Share in United States (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Dry Powder Inhaler Device Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Dry Powder Inhaler Device Sales Market Share in United States (2013-2018)
Figure Boehringer Ingelheim Dry Powder Inhaler Device Revenue Market Share in United States (2013-2018)
Table Chiesi Basic Information List
Table Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Chiesi Dry Powder Inhaler Device Sales Growth Rate (2013-2018)
Figure Chiesi Dry Powder Inhaler Device Sales Market Share in United States (2013-2018)
Figure Chiesi Dry Powder Inhaler Device Revenue Market Share in United States (2013-2018)
Table Cipla Basic Information List
Table Cipla Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cipla Dry Powder Inhaler Device Sales Growth Rate (2013-2018)
Figure Cipla Dry Powder Inhaler Device Sales Market Share in United States (2013-2018)
Figure Cipla Dry Powder Inhaler Device Revenue Market Share in United States (2013-2018)
Table 3M Basic Information List
Table 3M Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure 3M Dry Powder Inhaler Device Sales Growth Rate (2013-2018)
Figure 3M Dry Powder Inhaler Device Sales Market Share in United States (2013-2018)
Figure 3M Dry Powder Inhaler Device Revenue Market Share in United States (2013-2018)
Table Hovione Basic Information List
Table Hovione Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hovione Dry Powder Inhaler Device Sales Growth Rate (2013-2018)
Figure Hovione Dry Powder Inhaler Device Sales Market Share in United States (2013-2018)
Figure Hovione Dry Powder Inhaler Device Revenue Market Share in United States (2013-2018)
Table Mannkind Basic Information List
Table Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mannkind Dry Powder Inhaler Device Sales Growth Rate (2013-2018)
Figure Mannkind Dry Powder Inhaler Device Sales Market Share in United States (2013-2018)
Figure Mannkind Dry Powder Inhaler Device Revenue Market Share in United States (2013-2018)
Table Meda Basic Information List
Table Meda Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Meda Dry Powder Inhaler Device Sales Growth Rate (2013-2018)
Figure Meda Dry Powder Inhaler Device Sales Market Share in United States (2013-2018)
Figure Meda Dry Powder Inhaler Device Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Dry Powder Inhaler Device Sales Growth Rate (2013-2018)
Figure Novartis Dry Powder Inhaler Device Sales Market Share in United States (2013-2018)
Figure Novartis Dry Powder Inhaler Device Revenue Market Share in United States (2013-2018)
Table Schering/Merck Basic Information List
Table Teva Basic Information List
Table Vectura Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dry Powder Inhaler Device
Figure Manufacturing Process Analysis of Dry Powder Inhaler Device
Figure Dry Powder Inhaler Device Industrial Chain Analysis
Table Raw Materials Sources of Dry Powder Inhaler Device Major Players/Suppliers in 2017
Table Major Buyers of Dry Powder Inhaler Device
Table Distributors/Traders List
Figure United States Dry Powder Inhaler Device Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Dry Powder Inhaler Device Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Dry Powder Inhaler Device Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Dry Powder Inhaler Device Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Dry Powder Inhaler Device Sales Volume (K Units) Forecast by Type in 2025
Table United States Dry Powder Inhaler Device Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Dry Powder Inhaler Device Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Dry Powder Inhaler Device Sales Volume (K Units) Forecast by Application in 2025
Table United States Dry Powder Inhaler Device Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Dry Powder Inhaler Device Sales Volume Share Forecast by Region (2018-2025)
Figure United States Dry Powder Inhaler Device Sales Volume Share Forecast by Region (2018-2025)
Figure United States Dry Powder Inhaler Device Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Endometriosis - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 2000 Onwards        Pages: 135
    Endometriosis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometriosis - Pipeline Review, H2 2018, provides an overview of the Endometriosis (Women's Health) pipeline landscape. Endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (endometrium) grows outside uterus (endometrial implant). Symptoms include pelvic pain, menstrual cra......
  • Global Gene Delivery System Market Size, Status and Forecast 2018-2025
    Published: 18-Sep-2018        Price: US 3900 Onwards        Pages: 98
    This report focuses on the global Gene Delivery System status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Delivery System development in United States, Europe and China. Gene delivery systems are used to deliver therapeutic drugs targeting a specific area. Gene delivery is a procedure that introduces foreign DNA into host cells. In 2017, the global Gene Delivery System market size was xx million US$ and it i......
  • Global Deaf Aid Market Insights, Forecast to 2025
    Published: 18-Sep-2018        Price: US 4900 Onwards        Pages: 114
    This report studies the global market size of Deaf Aid in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Deaf Aid in these regions. This research report categorizes the global Deaf Aid market by top players/brands, region, type and end user. This report also studies the global Deaf Aid market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and chall......
  • 2018-2023 Global Contrast Media (Contrast Agents) Consumption Market Report
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 136
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Contrast Media (Contrast Agents) market for 2018-2023. Contrast media (or contrast agents) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast me......
  • 2018-2023 Global Closed System Drug Transfer Device (CSTD) Consumption Market Report
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 132
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Closed System Drug Transfer Device (CSTD) market for 2018-2023. Closed System Drug Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors int......
  • 2018-2023 Global Auto-Injectors Consumption Market Report
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 158
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Auto-Injectors market for 2018-2023. Auto-injector is a medical device designed to deliver a dose of a particular drug. Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug load......
  • 2018-2023 Global Viral Vectors and Plasmid DNA Manufacturing Market Report (Status and Outlook)
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 131
    In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Viral Vectors and Plasmid DNA Manufacturing market for 2018-2023. The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases. Based on classification, the proportion of Viral Vectors Manufacturing in 2016 is about 79.74%, with revenue about 200 M USD. Based on application, Cancers......
  • Global Transcatheter Heart Valves Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 117
    The sales volume of transcatheter heart valves is increasing across several healthcare centers due to the growing prevalence of various heart diseases such as cardio valvular diseases, mitral regurgitation, and aortic stenosis require valve replacement. Scope of the Report: This report focuses on the Transcatheter Heart Valves in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the m......
  • Global Transcatheter Aortic Valve Replacement Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 119
    Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. Whereas, the TAVR procedures can be done through very small openings ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs